Mathijs Bunck

Company: Eli Lilly & Company
Job title: Associate Vice President
Seminars:
The Next Wave of Therapeutics for CKD? Navigating Incretin-Based Therapies & the Kidney 8:00 am
• From pathogenesis to therapeutic intervention: incretin-based drugs and the kidney in type 2 diabetes • Developing incretin-based therapies for the treatment of kidney disease • Investigating the impact of multiple clinical comorbidities including cardiovascular diseases, NASH, and CKDRead more
day: Day One